nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—ESR2—ovarian follicle—polycystic ovary syndrome	0.0552	0.162	CbGeAlD
Fulvestrant—ESR1—ovarian follicle—polycystic ovary syndrome	0.0378	0.111	CbGeAlD
Fulvestrant—NR1H4—adrenal cortex—polycystic ovary syndrome	0.0133	0.039	CbGeAlD
Fulvestrant—EPHX2—adrenal cortex—polycystic ovary syndrome	0.0116	0.0341	CbGeAlD
Fulvestrant—ESRRA—adrenal cortex—polycystic ovary syndrome	0.0102	0.0299	CbGeAlD
Fulvestrant—Gastrointestinal symptom NOS—Metformin—polycystic ovary syndrome	0.00979	0.0923	CcSEcCtD
Fulvestrant—NR1H4—adrenal gland—polycystic ovary syndrome	0.0096	0.0282	CbGeAlD
Fulvestrant—EPHX2—uterus—polycystic ovary syndrome	0.00957	0.0281	CbGeAlD
Fulvestrant—EPHX2—pituitary gland—polycystic ovary syndrome	0.0094	0.0276	CbGeAlD
Fulvestrant—EPHX2—adipose tissue—polycystic ovary syndrome	0.00936	0.0274	CbGeAlD
Fulvestrant—ESRRA—endometrium—polycystic ovary syndrome	0.00909	0.0267	CbGeAlD
Fulvestrant—NR1H4—female gonad—polycystic ovary syndrome	0.00895	0.0263	CbGeAlD
Fulvestrant—CYP3A4—urine—polycystic ovary syndrome	0.00882	0.0259	CbGeAlD
Fulvestrant—EPHX2—adrenal gland—polycystic ovary syndrome	0.00839	0.0246	CbGeAlD
Fulvestrant—ESRRA—uterus—polycystic ovary syndrome	0.00838	0.0246	CbGeAlD
Fulvestrant—NR1H4—endocrine gland—polycystic ovary syndrome	0.00833	0.0244	CbGeAlD
Fulvestrant—ESRRA—pituitary gland—polycystic ovary syndrome	0.00823	0.0241	CbGeAlD
Fulvestrant—ESRRA—adipose tissue—polycystic ovary syndrome	0.0082	0.024	CbGeAlD
Fulvestrant—EPHX2—female gonad—polycystic ovary syndrome	0.00783	0.023	CbGeAlD
Fulvestrant—EPHX2—vagina—polycystic ovary syndrome	0.00778	0.0228	CbGeAlD
Fulvestrant—ESRRA—adrenal gland—polycystic ovary syndrome	0.00735	0.0216	CbGeAlD
Fulvestrant—ESRRA—female gonad—polycystic ovary syndrome	0.00686	0.0201	CbGeAlD
Fulvestrant—ESRRA—vagina—polycystic ovary syndrome	0.00681	0.02	CbGeAlD
Fulvestrant—Accidental injury—Metformin—polycystic ovary syndrome	0.00651	0.0613	CcSEcCtD
Fulvestrant—ESRRA—endocrine gland—polycystic ovary syndrome	0.00638	0.0187	CbGeAlD
Fulvestrant—ESR2—endometrium—polycystic ovary syndrome	0.00546	0.016	CbGeAlD
Fulvestrant—ESR1—embryo—polycystic ovary syndrome	0.00511	0.015	CbGeAlD
Fulvestrant—ESR2—uterus—polycystic ovary syndrome	0.00503	0.0147	CbGeAlD
Fulvestrant—ESR2—pituitary gland—polycystic ovary syndrome	0.00494	0.0145	CbGeAlD
Fulvestrant—Injury—Metformin—polycystic ovary syndrome	0.00455	0.0429	CcSEcCtD
Fulvestrant—ESR2—adrenal gland—polycystic ovary syndrome	0.00441	0.0129	CbGeAlD
Fulvestrant—Pain in extremity—Metformin—polycystic ovary syndrome	0.00418	0.0394	CcSEcCtD
Fulvestrant—ESR2—female gonad—polycystic ovary syndrome	0.00411	0.0121	CbGeAlD
Fulvestrant—ESR2—vagina—polycystic ovary syndrome	0.00409	0.012	CbGeAlD
Fulvestrant—ESR2—endocrine gland—polycystic ovary syndrome	0.00383	0.0112	CbGeAlD
Fulvestrant—Breast disorder—Metformin—polycystic ovary syndrome	0.00378	0.0356	CcSEcCtD
Fulvestrant—ESR1—endometrium—polycystic ovary syndrome	0.00374	0.011	CbGeAlD
Fulvestrant—Estradiol—SHBG—polycystic ovary syndrome	0.00364	0.414	CrCbGaD
Fulvestrant—Influenza—Metformin—polycystic ovary syndrome	0.00361	0.034	CcSEcCtD
Fulvestrant—ESR1—uterus—polycystic ovary syndrome	0.00344	0.0101	CbGeAlD
Fulvestrant—ESR1—pituitary gland—polycystic ovary syndrome	0.00338	0.00992	CbGeAlD
Fulvestrant—ESR1—adipose tissue—polycystic ovary syndrome	0.00337	0.00988	CbGeAlD
Fulvestrant—Infestation—Metformin—polycystic ovary syndrome	0.00322	0.0304	CcSEcCtD
Fulvestrant—Infestation NOS—Metformin—polycystic ovary syndrome	0.00322	0.0304	CcSEcCtD
Fulvestrant—Estradiol—AR—polycystic ovary syndrome	0.00319	0.363	CrCbGaD
Fulvestrant—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00305	0.0287	CcSEcCtD
Fulvestrant—ESR1—adrenal gland—polycystic ovary syndrome	0.00302	0.00886	CbGeAlD
Fulvestrant—Hepatitis—Metformin—polycystic ovary syndrome	0.00289	0.0272	CcSEcCtD
Fulvestrant—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00285	0.0268	CcSEcCtD
Fulvestrant—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00284	0.0268	CcSEcCtD
Fulvestrant—ESR1—female gonad—polycystic ovary syndrome	0.00282	0.00826	CbGeAlD
Fulvestrant—ESR1—vagina—polycystic ovary syndrome	0.0028	0.00821	CbGeAlD
Fulvestrant—Angiopathy—Metformin—polycystic ovary syndrome	0.00262	0.0247	CcSEcCtD
Fulvestrant—ESR1—endocrine gland—polycystic ovary syndrome	0.00262	0.00769	CbGeAlD
Fulvestrant—Immune system disorder—Metformin—polycystic ovary syndrome	0.00261	0.0246	CcSEcCtD
Fulvestrant—Malnutrition—Metformin—polycystic ovary syndrome	0.00252	0.0237	CcSEcCtD
Fulvestrant—Myalgia—Metformin—polycystic ovary syndrome	0.00214	0.0202	CcSEcCtD
Fulvestrant—Chest pain—Metformin—polycystic ovary syndrome	0.00214	0.0202	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00213	0.0201	CcSEcCtD
Fulvestrant—Infection—Metformin—polycystic ovary syndrome	0.00204	0.0192	CcSEcCtD
Fulvestrant—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00201	0.019	CcSEcCtD
Fulvestrant—Skin disorder—Metformin—polycystic ovary syndrome	0.002	0.0188	CcSEcCtD
Fulvestrant—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00199	0.0187	CcSEcCtD
Fulvestrant—Estradiol—CYP1A1—polycystic ovary syndrome	0.00197	0.223	CrCbGaD
Fulvestrant—Anorexia—Metformin—polycystic ovary syndrome	0.00196	0.0185	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00187	0.0176	CcSEcCtD
Fulvestrant—Paraesthesia—Metformin—polycystic ovary syndrome	0.00184	0.0174	CcSEcCtD
Fulvestrant—Dyspnoea—Metformin—polycystic ovary syndrome	0.00183	0.0173	CcSEcCtD
Fulvestrant—Dyspepsia—Metformin—polycystic ovary syndrome	0.00181	0.017	CcSEcCtD
Fulvestrant—Decreased appetite—Metformin—polycystic ovary syndrome	0.00179	0.0168	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00177	0.0167	CcSEcCtD
Fulvestrant—Fatigue—Metformin—polycystic ovary syndrome	0.00177	0.0167	CcSEcCtD
Fulvestrant—Constipation—Metformin—polycystic ovary syndrome	0.00176	0.0166	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00168	0.0158	CcSEcCtD
Fulvestrant—Urticaria—Metformin—polycystic ovary syndrome	0.00163	0.0154	CcSEcCtD
Fulvestrant—Abdominal pain—Metformin—polycystic ovary syndrome	0.00162	0.0153	CcSEcCtD
Fulvestrant—Asthenia—Metformin—polycystic ovary syndrome	0.00147	0.0139	CcSEcCtD
Fulvestrant—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00146	0.00429	CbGeAlD
Fulvestrant—Pruritus—Metformin—polycystic ovary syndrome	0.00145	0.0137	CcSEcCtD
Fulvestrant—Diarrhoea—Metformin—polycystic ovary syndrome	0.00141	0.0132	CcSEcCtD
Fulvestrant—Dizziness—Metformin—polycystic ovary syndrome	0.00136	0.0128	CcSEcCtD
Fulvestrant—Vomiting—Metformin—polycystic ovary syndrome	0.00131	0.0123	CcSEcCtD
Fulvestrant—Rash—Metformin—polycystic ovary syndrome	0.0013	0.0122	CcSEcCtD
Fulvestrant—Dermatitis—Metformin—polycystic ovary syndrome	0.00129	0.0122	CcSEcCtD
Fulvestrant—Headache—Metformin—polycystic ovary syndrome	0.00129	0.0121	CcSEcCtD
Fulvestrant—Nausea—Metformin—polycystic ovary syndrome	0.00122	0.0115	CcSEcCtD
Fulvestrant—ESR1—Signaling by ERBB4—NCOR1—polycystic ovary syndrome	0.000297	0.000546	CbGpPWpGaD
Fulvestrant—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000296	0.000544	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—RPL37A—polycystic ovary syndrome	0.000295	0.000542	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000293	0.000539	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—NRG1—polycystic ovary syndrome	0.000291	0.000536	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000291	0.000535	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—BAX—polycystic ovary syndrome	0.000291	0.000535	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—NAMPT—polycystic ovary syndrome	0.00029	0.000533	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—HSD3B2—polycystic ovary syndrome	0.00029	0.000533	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000289	0.00053	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000287	0.000527	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000285	0.000523	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000283	0.00052	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—AKR1C1—polycystic ovary syndrome	0.000281	0.000517	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—STAR—polycystic ovary syndrome	0.00028	0.000514	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	0.00028	0.000514	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.00028	0.000514	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—AR—polycystic ovary syndrome	0.000279	0.000512	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000277	0.000508	CbGpPWpGaD
Fulvestrant—ESRRA—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.000274	0.000504	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—TNRC6B—polycystic ovary syndrome	0.000274	0.000504	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—PGR—polycystic ovary syndrome	0.000271	0.000498	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000271	0.000497	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000266	0.00049	CbGpPWpGaD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000264	0.000485	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—LSM5—polycystic ovary syndrome	0.000264	0.000485	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	0.000259	0.000476	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—SULT2A1—polycystic ovary syndrome	0.000259	0.000475	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000256	0.000471	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—RRM2—polycystic ovary syndrome	0.000251	0.00046	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—IRS2—polycystic ovary syndrome	0.00025	0.000459	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—HMMR—polycystic ovary syndrome	0.000249	0.000458	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000247	0.000455	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000247	0.000455	CbGpPWpGaD
Fulvestrant—ESRRA—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.000247	0.000454	CbGpPWpGaD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000245	0.000451	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SAP30L—polycystic ovary syndrome	0.000245	0.000451	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	0.000244	0.000448	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—YAP1—polycystic ovary syndrome	0.000241	0.000444	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000241	0.000443	CbGpPWpGaD
Fulvestrant—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000239	0.00044	CbGpPWpGaD
Fulvestrant—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000239	0.000439	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000238	0.000437	CbGpPWpGaD
Fulvestrant—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000236	0.000434	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000235	0.000432	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000235	0.000431	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—NAMPT—polycystic ovary syndrome	0.000232	0.000426	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000231	0.000424	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—TH—polycystic ovary syndrome	0.000231	0.000424	CbGpPWpGaD
Fulvestrant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00023	0.000422	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CYP11A1—polycystic ovary syndrome	0.000229	0.000421	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000227	0.000418	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—YAP1—polycystic ovary syndrome	0.000227	0.000417	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	0.000225	0.000414	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000224	0.000412	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000223	0.00041	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—IRS1—polycystic ovary syndrome	0.000219	0.000403	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—IRS1—polycystic ovary syndrome	0.000218	0.000401	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000218	0.0004	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—LHB—polycystic ovary syndrome	0.000217	0.000399	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—AKR1C3—polycystic ovary syndrome	0.000216	0.000398	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CYP17A1—polycystic ovary syndrome	0.000213	0.000392	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—HSD3B2—polycystic ovary syndrome	0.000212	0.00039	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—AR—polycystic ovary syndrome	0.000211	0.000388	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000211	0.000388	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—TEAD2—polycystic ovary syndrome	0.000209	0.000383	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	0.000207	0.00038	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—AKR1C1—polycystic ovary syndrome	0.000205	0.000378	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—AKT2—polycystic ovary syndrome	0.000202	0.000371	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.000201	0.000369	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—TNRC6B—polycystic ovary syndrome	0.0002	0.000368	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—PGR—polycystic ovary syndrome	0.000198	0.000364	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—YAP1—polycystic ovary syndrome	0.000198	0.000363	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—IL6—polycystic ovary syndrome	0.000194	0.000357	CbGpPWpGaD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000194	0.000357	CbGpPWpGaD
Fulvestrant—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000193	0.000355	CbGpPWpGaD
Fulvestrant—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00019	0.00035	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—SULT2A1—polycystic ovary syndrome	0.000189	0.000347	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—GNAS—polycystic ovary syndrome	0.000188	0.000346	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—NCOR1—polycystic ovary syndrome	0.000184	0.000339	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—TH—polycystic ovary syndrome	0.000184	0.000339	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—RRM2—polycystic ovary syndrome	0.000183	0.000336	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—PGR—polycystic ovary syndrome	0.000181	0.000332	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.000181	0.000332	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—SLC2A4—polycystic ovary syndrome	0.000179	0.00033	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—NCOR1—polycystic ovary syndrome	0.000179	0.00033	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—BCL2—polycystic ovary syndrome	0.000177	0.000326	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000177	0.000326	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—YAP1—polycystic ovary syndrome	0.000176	0.000324	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	0.000175	0.000321	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—TNRC6B—polycystic ovary syndrome	0.000174	0.00032	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—PGR—polycystic ovary syndrome	0.000173	0.000317	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000172	0.000315	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—NR3C1—polycystic ovary syndrome	0.000171	0.000313	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—CYP1A1—polycystic ovary syndrome	0.00017	0.000312	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL6—polycystic ovary syndrome	0.00017	0.000312	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00017	0.000312	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—NAMPT—polycystic ovary syndrome	0.00017	0.000312	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CYP19A1—polycystic ovary syndrome	0.000169	0.00031	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000169	0.00031	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000168	0.000309	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CYP11A1—polycystic ovary syndrome	0.000167	0.000308	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000166	0.000306	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—MTHFR—polycystic ovary syndrome	0.000158	0.000291	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000158	0.000291	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—AKR1C3—polycystic ovary syndrome	0.000158	0.000291	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	0.000157	0.000289	CbGpPWpGaD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000156	0.000288	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000156	0.000287	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CYP17A1—polycystic ovary syndrome	0.000156	0.000286	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—AR—polycystic ovary syndrome	0.000154	0.000283	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GNAS—polycystic ovary syndrome	0.00015	0.000277	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NPB—polycystic ovary syndrome	0.00015	0.000276	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—RPL37A—polycystic ovary syndrome	0.000149	0.000273	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000147	0.00027	CbGpPWpGaD
Fulvestrant—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000144	0.000264	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—NCOR1—polycystic ovary syndrome	0.000143	0.000263	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—AR—polycystic ovary syndrome	0.000141	0.000258	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00014	0.000258	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000138	0.000254	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—CYP1A1—polycystic ovary syndrome	0.000136	0.00025	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000136	0.000249	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—NCOR1—polycystic ovary syndrome	0.000135	0.000248	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—TH—polycystic ovary syndrome	0.000135	0.000248	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—AR—polycystic ovary syndrome	0.000134	0.000247	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000133	0.000244	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—PPARG—polycystic ovary syndrome	0.000132	0.000243	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—SLC2A4—polycystic ovary syndrome	0.000131	0.000241	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000131	0.00024	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00013	0.000239	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000129	0.000236	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PPARG—polycystic ovary syndrome	0.000128	0.000236	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—POMC—polycystic ovary syndrome	0.000127	0.000233	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—MTHFR—polycystic ovary syndrome	0.000127	0.000233	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—INS—polycystic ovary syndrome	0.000126	0.000232	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000125	0.00023	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000125	0.00023	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—NR3C1—polycystic ovary syndrome	0.000125	0.000229	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CYP19A1—polycystic ovary syndrome	0.000123	0.000226	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	0.000123	0.000226	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—SERPINE1—polycystic ovary syndrome	0.000119	0.000219	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—NCOR1—polycystic ovary syndrome	0.000117	0.000216	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000117	0.000215	CbGpPWpGaD
Fulvestrant—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000117	0.000214	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	0.000114	0.000209	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000114	0.000209	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000111	0.000203	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GNAS—polycystic ovary syndrome	0.00011	0.000202	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.00011	0.000202	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—NR3C1—polycystic ovary syndrome	0.000109	0.0002	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000108	0.000198	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—NCOR1—polycystic ovary syndrome	0.000105	0.000193	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000103	0.00019	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PPARG—polycystic ovary syndrome	0.000103	0.000189	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000102	0.000187	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—POMC—polycystic ovary syndrome	0.000101	0.000186	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—INS—polycystic ovary syndrome	0.000101	0.000185	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000101	0.000185	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—YAP1—polycystic ovary syndrome	9.97e-05	0.000183	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—CYP1A1—polycystic ovary syndrome	9.93e-05	0.000183	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—PPARG—polycystic ovary syndrome	9.65e-05	0.000177	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—MTHFR—polycystic ovary syndrome	9.26e-05	0.00017	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FSHR—polycystic ovary syndrome	9.16e-05	0.000168	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—IL6—polycystic ovary syndrome	9.12e-05	0.000168	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	8.81e-05	0.000162	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—TNRC6B—polycystic ovary syndrome	8.79e-05	0.000162	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PGR—polycystic ovary syndrome	8.7e-05	0.00016	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—SERPINE1—polycystic ovary syndrome	8.7e-05	0.00016	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	8.61e-05	0.000158	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—PPARG—polycystic ovary syndrome	8.41e-05	0.000155	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	8.38e-05	0.000154	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	8.31e-05	0.000153	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	8.2e-05	0.000151	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FST—polycystic ovary syndrome	8.16e-05	0.00015	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADRB3—polycystic ovary syndrome	8.06e-05	0.000148	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—LHB—polycystic ovary syndrome	7.97e-05	0.000146	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	7.93e-05	0.000146	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GNRH1—polycystic ovary syndrome	7.79e-05	0.000143	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—SERPINE1—polycystic ovary syndrome	7.57e-05	0.000139	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	7.54e-05	0.000139	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PPARG—polycystic ovary syndrome	7.51e-05	0.000138	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SCT—polycystic ovary syndrome	7.47e-05	0.000137	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—POMC—polycystic ovary syndrome	7.4e-05	0.000136	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—INS—polycystic ovary syndrome	7.36e-05	0.000135	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	7.31e-05	0.000134	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	7.12e-05	0.000131	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FGF18—polycystic ovary syndrome	7e-05	0.000129	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RBP4—polycystic ovary syndrome	6.94e-05	0.000128	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—AR—polycystic ovary syndrome	6.77e-05	0.000124	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	6.69e-05	0.000123	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	6.69e-05	0.000123	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—YAP1—polycystic ovary syndrome	6.48e-05	0.000119	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GAB1—polycystic ovary syndrome	6.39e-05	0.000117	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	6.22e-05	0.000114	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	6.2e-05	0.000114	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—INSR—polycystic ovary syndrome	6.11e-05	0.000112	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NCOR1—polycystic ovary syndrome	5.92e-05	0.000109	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	5.81e-05	0.000107	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	5.72e-05	0.000105	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PGR—polycystic ovary syndrome	5.66e-05	0.000104	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—NR3C1—polycystic ovary syndrome	5.47e-05	0.000101	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	5.29e-05	9.71e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	5.29e-05	9.71e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PLAT—polycystic ovary syndrome	5.26e-05	9.67e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GHRL—polycystic ovary syndrome	5.26e-05	9.67e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ATF1—polycystic ovary syndrome	5.02e-05	9.22e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	4.89e-05	8.99e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NGFR—polycystic ovary syndrome	4.63e-05	8.51e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PRL—polycystic ovary syndrome	4.59e-05	8.44e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	4.43e-05	8.14e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADRB2—polycystic ovary syndrome	4.35e-05	8e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PPARG—polycystic ovary syndrome	4.24e-05	7.79e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	4.2e-05	7.72e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GNAS—polycystic ovary syndrome	4.04e-05	7.42e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	4.01e-05	7.36e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.85e-05	7.07e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SERPINE1—polycystic ovary syndrome	3.82e-05	7.02e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NRG1—polycystic ovary syndrome	3.78e-05	6.94e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	3.57e-05	6.56e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	3.41e-05	6.26e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IRS2—polycystic ovary syndrome	3.23e-05	5.94e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—LEP—polycystic ovary syndrome	3.16e-05	5.82e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	3.11e-05	5.71e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	3.04e-05	5.58e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	2.94e-05	5.4e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IRS1—polycystic ovary syndrome	2.82e-05	5.19e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—POMC—polycystic ovary syndrome	2.72e-05	5e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	2.71e-05	4.97e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—INS—polycystic ovary syndrome	2.7e-05	4.97e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	2.62e-05	4.82e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IGF1—polycystic ovary syndrome	2.61e-05	4.81e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AKT2—polycystic ovary syndrome	2.61e-05	4.8e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	2.53e-05	4.64e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.48e-05	4.56e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	2.43e-05	4.46e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	2.4e-05	4.41e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	2.26e-05	4.16e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	2.23e-05	4.1e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—TH—polycystic ovary syndrome	1.93e-05	3.54e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	1.88e-05	3.45e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	1.76e-05	3.24e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.71e-05	3.14e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	1.57e-05	2.89e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.5e-05	2.76e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.42e-05	2.61e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.33e-05	2.44e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL6—polycystic ovary syndrome	1.18e-05	2.17e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.07e-05	1.97e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.06e-05	1.95e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.05e-05	1.94e-05	CbGpPWpGaD
